Oliver Strobel
Oliver Strobel is an expert in Surgery at University Hospital Heidelberg (Germany). As of October 2026, ScienceLeadR ranks Oliver Strobel in the top 1% of experts worldwide for Pancreatic Neoplasms, Pancreatic Diseases and Endocrine Gland Neoplasms. Oliver Strobel has authored 504 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 1,505 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Oncology - Gastroenterology - Hepatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2003 - 2026
Number : 504
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Completion, publication, and outcome reporting of registered randomized trials in abdominal surgery: registry-based cohort study. PMID 42925089 — registries, surgical procedures, operative, cohort studies | BJS Open | 2026 | 0 |
| Predictive Value of the ALBI Grade for Short-Term Morbidity and Mortality After Pancreatoduodenectomy. PMID 42738417 — mortality, hyperbilirubinemia, pancreaticoduodenectomy, predictive value of tests, liver, morbidity, roc curve, postoperative complications, bilirubin, hypoalbuminemia | Cancers (Basel) | 2026 | 0 |
| R0 Resection improves survival after multivisceral resection for pancreatic ductal adenocarcinoma. PMID 42733466 — adenocarcinoma | iScience | 2026 | 0 |
| Perioperative outcomes and long-term survival following resection of gallbladder cancer in older adults: retrospective study. PMID 42536426 — gallbladder, surgical procedures, operative, retrospective studies, neoplasms, drug therapy, aged, chemotherapy, adjuvant, morbidity, gallbladder neoplasms, therapeutics, cholangiocarcinoma, chemotherapy | BJS Open | 2026 | 0 |
| Liver perfusion failure after pancreatoduodenectomy: clinical significance and perioperative risk factors. PMID 42479666 — pancreatic neoplasms, surgical procedures, operative, pancreaticoduodenectomy, transaminases, liver, risk factors, pancreatic fistula, postoperative complications | BJS Open | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 3
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| The HELPP Score A Pretreatment Score to Predict Survival in Pancreatic Cancer NCT05752812 — pancreatic neoplasms, neoplasms, adenocarcinoma | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map